Italy Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Italy Biotechnology Market @Summary, Competitive Analysis and Forecast, 2017-2026
SUMMARY
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Italian biotechnology market had total revenues of $28.1 billion in 2021, representing a compound annual growth rate (CAGR) of 24.1% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $11.7 billion, equivalent to 41.7% of the market's overall value.
- Italy has sought to establish itself as a major competitor in the European biotechnology market. This is evidenced by the fact that it currently has the largest biotech market in Europe, accounting for 17.8% of the regional market value in 2021.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
- What was the size of the Italy biotechnology market by value in 2021?
- What will be the size of the Italy biotechnology market in 2026?
- What factors are affecting the strength of competition in the Italy biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in Italy's biotechnology market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Do leading players have any notable weaknesses?
7.4. What has been the most significant M&A activity this year?
8 COMPANY PROFILES
8.1. A Menarini Industrie Farmaceutiche Riunite Srl
8.2. Recordati S.p.A.
8.3. AGC Biologics SpA
8.4. Zambon Co SpA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. Do leading players have any notable weaknesses?
7.4. What has been the most significant M&A activity this year?
8 COMPANY PROFILES
8.1. A Menarini Industrie Farmaceutiche Riunite Srl
8.2. Recordati S.p.A.
8.3. AGC Biologics SpA
8.4. Zambon Co SpA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Italy biotechnology industry value: $ billion, 2016–21
Table 2: Italy biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Italy biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Italy biotechnology industry geography segmentation: $ billion, 2021
Table 5: Italy biotechnology industry value forecast: $ billion, 2021–26
Table 6: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 7: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 8: Recordati S.p.A.: key facts
Table 9: Recordati S.p.A.: Annual Financial Ratios
Table 10: Recordati S.p.A.: Key Employees
Table 11: AGC Biologics SpA: key facts
Table 12: AGC Biologics SpA: Key Employees
Table 13: Zambon Co SpA: key facts
Table 14: Zambon Co SpA: Key Employees
Table 15: Italy size of population (million), 2017–21
Table 16: Italy gdp (constant 2005 prices, $ billion), 2017–21
Table 17: Italy gdp (current prices, $ billion), 2017–21
Table 18: Italy inflation, 2017–21
Table 19: Italy consumer price index (absolute), 2017–21
Table 20: Italy exchange rate, 2017–21
Table 1: Italy biotechnology industry value: $ billion, 2016–21
Table 2: Italy biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Italy biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Italy biotechnology industry geography segmentation: $ billion, 2021
Table 5: Italy biotechnology industry value forecast: $ billion, 2021–26
Table 6: A Menarini Industrie Farmaceutiche Riunite Srl: key facts
Table 7: A Menarini Industrie Farmaceutiche Riunite Srl: Key Employees
Table 8: Recordati S.p.A.: key facts
Table 9: Recordati S.p.A.: Annual Financial Ratios
Table 10: Recordati S.p.A.: Key Employees
Table 11: AGC Biologics SpA: key facts
Table 12: AGC Biologics SpA: Key Employees
Table 13: Zambon Co SpA: key facts
Table 14: Zambon Co SpA: Key Employees
Table 15: Italy size of population (million), 2017–21
Table 16: Italy gdp (constant 2005 prices, $ billion), 2017–21
Table 17: Italy gdp (current prices, $ billion), 2017–21
Table 18: Italy inflation, 2017–21
Table 19: Italy consumer price index (absolute), 2017–21
Table 20: Italy exchange rate, 2017–21
LIST OF FIGURES
Figure 1: Italy biotechnology industry value: $ billion, 2016–21
Figure 2: Italy biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Italy biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2021
Figure 1: Italy biotechnology industry value: $ billion, 2016–21
Figure 2: Italy biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Italy biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Italy biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Italy, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Italy, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Italy, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Italy, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Italy, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Italy, 2021
